Ontology highlight
ABSTRACT: Background
Botulinum toxin type A is currently strongly recommended for the treatment of anal fissures (AFs). However, there is still no consensus on dosage or injection technique. This study provides further efficacy and safety evidence in a 2-year follow-up.Method
Prospective, open-label, single-arm, single-center study carried out in adult patients with AFs non-responsive to previous treatments. Patients were treated with incobotulinumtoxinA (incoBoNT/A) injected in both laterals and posterior intersphincteric groove. Healing rate at 2 years was the primary endpoint. Secondary endpoints included internal anal sphincter pressures, incontinence, and safety.Results
A total of 49 patients were treated with a mean incoBoNT/A dose of 40.5 U (spread across three locatio
SUBMITTER: Calderon T
PROVIDER: S-EPMC11440925 | biostudies-literature | 2024 Sep
REPOSITORIES: biostudies-literature